Mar­ket­ingRx roundup: Ab­b­Vie dri­ves en­dometrio­sis aware­ness; No­var­tis adds to Cosen­tyx cam­paign

3 years ago
Pharma
Marketing

Fer­ring clos­es key re­search site, let­ting go 89 work­ers in San Diego

3 years ago
People

Bio­mea Fu­sion stock soars on ear­ly-stage di­a­betes da­ta

3 years ago
Discovery

Tiny mul­ti­omics biotech se­cures for­mer J&J drug, new ex­ecs and new fi­nanc­ing

3 years ago
Financing
Startups

In­tra-Cel­lu­lar Ther­a­pies gets a boost on PhI­II de­pres­sion drug da­ta

3 years ago
R&D

Evotec’s CNS deal with Bris­tol My­ers gets $50M in­fu­sion and eight-year ex­ten­sion

3 years ago
Deals
Pharma

Pri­vate eq­ui­ty firm taps ex-Ed­i­tas CEO Jim Mullen to help ex­pand phar­ma port­fo­lio — with a nod to cell, gene ...

3 years ago
People

Viking soars on ear­ly-stage weight loss da­ta as it maps out PhII

3 years ago
R&D

No­var­tis rides with Bi­cy­cle for new pact on tar­get­ed ra­dio­ther­a­pies

3 years ago
Deals

With Boehringer In­gel­heim’s help, Roivant churns out an­oth­er Vant to go up against En­deav­or, Im­pact founders

3 years ago
Financing
Startups

Gun­ning for 2023 ap­proval, GSK de­tails PhI­II da­ta for Jem­per­li in front­line en­dome­tri­al can­cer

3 years ago
R&D
Pharma

Ab­b­Vie drops Cy­tomX part­ner­ship, leav­ing PhII pro­gram in the air

3 years ago
Deals

Jef­frey Blue­stone brings his start­up haul to $400M+, join­ing forces with Re­gen­eron on cell ther­a­pies

3 years ago
Financing
Bioregnum

Ap­plied Mol­e­c­u­lar Trans­port pre­pares to close up shop as it paus­es R&D, re­places CEO, lays off 57%

3 years ago
People
R&D

Mer­ck touts PhI­II Keytru­da da­ta in front­line en­dome­tri­al can­cer

3 years ago
R&D

Es­pe­ri­on sues Dai­ichi Sankyo, de­mand­ing pay­ment of $300M mile­stone for car­dio drug

3 years ago
Pharma
Law

Heat­ed oral ar­gu­ments at SCO­TUS hint at Sanofi-Re­gen­eron edge over Am­gen in patent spat

3 years ago
Law

Mer­ck KGaA takes back con­trol of PD-L1 can­cer drug as Pfiz­er al­liance ends

3 years ago
Deals
Pharma

Eli Lil­ly to in­crease in­vest­ment to $1B in­to new Irish man­u­fac­tur­ing fa­cil­i­ty — re­port

3 years ago
Pharma
Manufacturing

Sen­a­tor asks FTC to in­ves­ti­gate Amerisource­Ber­gen over abor­tion pill dis­tri­b­u­tion plans

3 years ago
Pharma

Re­silience notch­es $410M in fed­er­al fi­nanc­ing to bol­ster pro­duc­tion

3 years ago
Financing
Pharma

BioN­Tech read­ies for plunge in Covid sales, will boost mR­NA and on­col­o­gy pipelines

3 years ago
Pharma

Gami­da Cell makes more staff cuts and re­struc­tures as it fo­cus­es on po­ten­tial drug launch

3 years ago
People
R&D

Ver­tex ponies up $100M for CRISPR's gene edit­ing tech to de­vel­op new di­a­betes modal­i­ty

3 years ago
Deals
R&D
First page Previous page 367368369370371372373 Next page Last page
A service from the Financial Times